Literature DB >> 7536440

Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.

J Bies1, R Mukhopadhyaya, J Pierce, L Wolff.   

Abstract

In murine leukemia virus-induced myeloid leukemias, insertional mutagenesis of the c-myb locus has been shown to occur frequently. Proto-oncogene activation is achieved in most leukemias by integration of murine leukemia virus upstream of exons 3 or 4 or by integration into exon 9 with consequent truncation of the protein. The present study investigates the effect of ectopic expression of full-length c-myb or c-myb containing amino- or carboxyl-terminal truncations (minus 47 and 248 amino acids, respectively) on granulocyte differentiation in vitro. Recombinant myb retroviruses were used to infect an interleukin 3-dependent progenitor cell line, 32Dcl3, which undergoes terminal differentiation to mature neutrophilic granulocytes in the presence of granulocyte colony-stimulating factor. Overexpression of c-myb did not abrogate the interleukin 3 dependency of the parental cell line. However, cells expressing all forms of c-myb were blocked at an intermediate stage of granulocyte differentiation and continued to proliferate in the presence of granulocyte colony-stimulating factor. After 14 days in medium with granulocyte colony-stimulating factor, myb-expressing cultures predominantly consisted of promyelocytes with some myelocytes and almost undetectable numbers of neutrophilic granulocytes. This suggested that early stages of granulocyte differentiation were not inhibited, a finding that was further supported by the induction of myeloperoxidase, a biochemical marker of promyelocytes. Interestingly, the expression of lactoferrin, known to be a marker of late stages of granulocyte differentiation, was completely inhibited in the cells infected with myb viruses. It was concluded that c-myb expression blocked granulocyte differentiation to the terminal mitotic stages and that deletion of the NH2-terminal 47 amino acids and/or the COOH-terminal 248 amino acids of c-myb neither enhanced nor diminished this effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536440

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

1.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

Review 2.  Transcriptional regulation of myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

Review 3.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

4.  Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.

Authors:  M Schmidt; V Nazarov; L Stevens; R Watson; L Wolff
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Authors:  Yuji Nakata; Susan Shetzline; Chizuko Sakashita; Anna Kalota; Ravikumar Rallapalli; Stephen I Rudnick; Yi Zhang; Stephen G Emerson; Alan M Gewirtz
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

6.  The C-terminal domain of B-Myb acts as a positive regulator of transcription and modulates its biological functions.

Authors:  I H Oh; E P Reddy
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.

Authors:  J Bies; V Nazarov; L Wolff
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb.

Authors:  Atul Kumar; Stacey J Baker; Clement M Lee; E Premkumar Reddy
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts.

Authors:  C H Woo; L Sopchak; J S Lipsick
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability.

Authors:  Jason Ernst; Louis Ghanem; Ziv Bar-Joseph; Michael McNamara; Jason Brown; Richard A Steinman
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.